Is Sunlight Deprivation Triggering Suicides?

As reported by Jeff Nicklas Vitamin D Council (10/14) Inflammation And Suicide Attempts: Where Does Vitamin D Fit In?

In a new study from the journal Psychoneuroendocrinology, researchers found a high prevalence of vitamin D deficiency in suicidal patients, as well as a negative correlation between vitamin D levels and pro-inflammatory markers.

Suicide is a complex event that involves a multitude of genetic, environmental and psychological influences. It is widely known that psychological conditions such as depression, stress, personality disorders, and other forms of mental illness play a major role leading up to a suicide attempt. What is less understood is how the unique biological markers seen in suicidal patients contribute to suicidal behavior. Previous evidence suggests that inflammation can contribute to depressive disorders, which in turn increases the odds of a suicide attempt.

Taking this a step further, researchers have found that patients who attempt suicide have elevated levels of pro-inflammatory markers such as interleukin-6 (IL-6) and C-reactive proteins when compared to depressed patients who were non-suicidal. While these studies support the hypothesis that inflammation is an underlying factor in those who attempt suicide, the cause of that inflammation remains unknown.

Researchers of the current study speculated that vitamin D, a known modulator of inflammation, may be involved in the etiology of suicide attempts and could subsequently be a cheap and effective therapy in these patients. To test their hypothesis, Dr. Cécile Grudet and her research team out of Sweden enrolled participants from three distinct groups. They recruited 59 patients who had been admitted to Lund University Hospital after a suicide attempt, 17 patients with major depressive disorder but who were non-suicidal, and 14 healthy participants from the surrounding area to serve as a control group. All participants underwent a structured interview by a psychiatrist in order to detect any psychiatric disorders and determine the severity of these disorders. Blood samples were then taken within a week after the interview. The researchers used these blood samples to measure the participants’ inflammatory markers, including IL-6, interleukin 1-beta (IL-1β) and tumor necrosis factor alpha (TNF-α), as well as their vitamin D status. IL-1β is an important inflammatory marker that is associated with pain sensitivity in the . TNF-α is an inflammatory cytokine produced by adipose tissue and is responsible for immune regulation. Improperly functioning TNF-α has been implicated in the development of depression.

The researchers wanted to determine the prevalence of vitamin D deficiency, defined as having levels below 20 ng/ml, and whether this deficiency was correlated with increased inflammatory markers in suicidal patients when compared to non-suicidal depressed patients and the control group. Here’s what the researchers found:

• Overall, 92% of the suicidal patients had 25(OH)D levels below 30 ng/ml compared to 59% in the non-suicidal depressed patients and 71% in the control group (P < 0.01).
• The average vitamin D level in the suicidal patients was significantly lower than the other groups with an average of 18.8 ng/ml, compared to 24.8 ng/ml in the non-suicidal depressed patients, and 26 ng/ml in the healthy control group (P < 0.05).
• There was no significant difference in vitamin D levels based on psychiatric diagnosis or severity of the disorder.
• A significant negative relationship was observed between vitamin D and IL-1β in the suicide attempters (P < 0.05).
• There was a significant negative correlation between vitamin D and IL-6 in the non-suicidal depressed patients (P < 0.05).
• There was no significant effect of psychiatric medications or anti-epileptic drugs on vitamin D in any of the participants.

The researchers concluded,  “As we and others have previously shown that peripheral and central inflammation is increased in suicidal patients, we here suggest that low levels of vitamin D could be a contributing cause of this inflammation.” They went on to add, “As inflammation is suggested to directly be part of the neural mechanisms underlying depressive and suicidal behavior, it should be of high relevance to detect and cure the vitamin D deficiency in these patients.”

The researchers acknowledge a few key factors missing from their analysis. They did not collect data on the participants’ ethnicity, sun exposure behavior, or smoking habits, which may impact their results.  As with other observational studies, the design limits the ability to know for sure whether vitamin D deficiency causes increased inflammation or suicide attempts.

While this research hints at the possibility that vitamin D may influence biological factors relating to suicides, it is important to keep in mind the complex nature of suicidal behaviors. These events often arise from life issues, such as social or financial problems, and may not be able to be controlled through nutritional or medical intervention. Nonetheless, if biological factors do significantly contribute to risk of suicide attempt then, as the researchers mention, vitamin D may be a cost-effective and easily administered therapy to help in those with suicidal behaviors. For this reason, clinical trials looking at how vitamin D supplementation to treat deficiency affects suicidal behavior are still needed.

related articles:

Finally: Missing Link Between Vitamin D, Prostate Cancer

From ScienceDaily (10/14):
A University of Colorado Cancer Center study published in the journal Prostate offers compelling evidence that inflammation may be the link between Vitamin D and prostate cancer. Specifically, the study shows that the gene GDF-15, known to be upregulated by Vitamin D, is notably absent in samples of human prostate cancer driven by inflammation. "When you take Vitamin D and put it on prostate cancer cells, it inhibits their growth. But it hasn't been proven as an anti-cancer agent. We wanted to understand what genes Vitamin D is turning on or off in prostate cancer to offer new targets," says James R. Lambert, PhD, investigator at the CU Cancer Center and associate research professor in the CU School of Medicine Department of Pathology.

Since demonstrating that Vitamin D upregulates the expression of GDF-15, Lambert and colleagues, including Scott Lucia, MD, wondered if this gene might be a mechanism through which Vitamin D works in prostate cancer. Initially it seemed as if the answer was no. "We thought there might be high levels of GDF-15 in normal tissue and low levels in prostate cancer, but we found that in a large cohort of human prostate tissue samples, expression of GDF-15 did not track with either normal or cancerous prostate tissue," Lambert says. But then the team noticed an interesting pattern: GDF-15 was uniformly low in samples of prostate tissue that contained inflammation. "Inflammation is thought to drive many cancers including prostate, gastric and colon. Therefore, GDF-15 may be a good thing in keeping prostate tissue healthy -- it suppresses inflammation, which is a bad actor potentially driving prostate cancer," Lambert says.

The study used a sophisticated computer algorithm to analyze immunohistochemical (IHC) data, a task that in previous studies had been done somewhat subjectively by pathologists. With this new technique, Lambert, Lucia and colleagues were able to quantify the expression of the GDF-15 protein and inflammatory cells by IHC staining on slides taken from these human prostate samples. Additionally encouraging is that the gene GDF-15 was shown to suppress inflammation by inhibiting another target, NFkB. This target, NFkB, has been the focus of many previous studies in which it has been shown to promote inflammation and contribute to tumor formation and growth; however, researchers have previously been unable to drug NFkB to decrease its tumor-promoting behavior. "There's been a lot of work on inhibiting NFkB," says Lambert. "Now from this starting point of Vitamin D in prostate cancer, we've come a long way toward understanding how we might use GDF-15 to target NFkB, which may have implications in cancer types far beyond prostate."

The above story is based on materials provided by University of Colorado Denver.
Tan Plus Products
Essentials Products

Tanning & Natural Health News is a publication of Tan Plus /Essentials Of Life, Barclay Square, 350 Route 108, Somersworth, NH. This publication is designed for educational purposes only and is not intended to be presented as medical advice. Product statements made have not been evaluated by the Food & Drug Administration.

Copyright © 2014 • Ray Allard • All Rights Reserved

 Experience “Real Health” Naturally
Tanning & Natural Health News